L&C Bio Past Earnings Performance

Past criteria checks 5/6

L&C Bio has been growing earnings at an average annual rate of 36.8%, while the Biotechs industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 22.2% per year. L&C Bio's return on equity is 30.9%, and it has net margins of 70.2%.

Key information

36.8%

Earnings growth rate

34.8%

EPS growth rate

Biotechs Industry Growth11.7%
Revenue growth rate22.2%
Return on equity30.9%
Net Margin70.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions

Mar 27
L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions

L&C Bio's (KOSDAQ:290650) Earnings Are Of Questionable Quality

Apr 01
L&C Bio's (KOSDAQ:290650) Earnings Are Of Questionable Quality

Recent updates

L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions

Mar 27
L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions

Does L&C Bio (KOSDAQ:290650) Deserve A Spot On Your Watchlist?

Apr 20
Does L&C Bio (KOSDAQ:290650) Deserve A Spot On Your Watchlist?

L&C Bio's (KOSDAQ:290650) Earnings Are Of Questionable Quality

Apr 01
L&C Bio's (KOSDAQ:290650) Earnings Are Of Questionable Quality

Is L&C Bio (KOSDAQ:290650) A Risky Investment?

Mar 02
Is L&C Bio (KOSDAQ:290650) A Risky Investment?

Announcing: L&C Bio (KOSDAQ:290650) Stock Increased An Energizing 163% In The Last Year

Feb 03
Announcing: L&C Bio (KOSDAQ:290650) Stock Increased An Energizing 163% In The Last Year

What Is The Ownership Structure Like For L&C Bio Co., Ltd (KOSDAQ:290650)?

Jan 04
What Is The Ownership Structure Like For L&C Bio Co., Ltd (KOSDAQ:290650)?

Should You Be Excited About L&C Bio Co., Ltd's (KOSDAQ:290650) 16% Return On Equity?

Dec 08
Should You Be Excited About L&C Bio Co., Ltd's (KOSDAQ:290650) 16% Return On Equity?

Revenue & Expenses Breakdown
Beta

How L&C Bio makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A290650 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2368,87048,36120,9413,838
30 Sep 2367,48753,59318,3322,823
30 Jun 2359,7164,11415,6932,823
31 Mar 2356,3703,88214,2692,341
31 Dec 2252,5724,54413,9412,195
30 Sep 2250,39911,09213,3822,728
30 Jun 2249,55312,53013,0762,728
31 Mar 2247,10113,17611,6022,786
31 Dec 2145,67713,81412,0572,295
30 Sep 2141,57911,02112,2362,445
30 Jun 2137,95611,14610,6962,445
31 Mar 2135,14111,10710,9082,448
31 Dec 2032,97310,8139,5552,381
30 Sep 2031,8687,2138,3101,792
30 Jun 2030,4106,9788,1331,792
31 Mar 2030,3337,2887,9521,672
31 Dec 1929,1527,2508,0231,346
30 Sep 1927,3486,5057,9011,554
30 Jun 1924,9785,8607,3131,554
31 Mar 1922,6245,5216,9461,421
31 Dec 1821,2415,2086,5431,268
30 Sep 1819,6185,1865,7151,020
30 Jun 1819,9665,3965,1011,218
31 Mar 1818,6314,3454,8211,244
31 Dec 1717,9013,7535,263918

Quality Earnings: A290650 has a high level of non-cash earnings.

Growing Profit Margin: A290650's current net profit margins (70.2%) are higher than last year (8.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A290650's earnings have grown significantly by 36.8% per year over the past 5 years.

Accelerating Growth: A290650's earnings growth over the past year (964.2%) exceeds its 5-year average (36.8% per year).

Earnings vs Industry: A290650 earnings growth over the past year (964.2%) exceeded the Biotechs industry 28.8%.


Return on Equity

High ROE: A290650's Return on Equity (30.9%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.